Your browser doesn't support javascript.
loading
Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
Condorelli, R; Mosele, F; Verret, B; Bachelot, T; Bedard, P L; Cortes, J; Hyman, D M; Juric, D; Krop, I; Bieche, I; Saura, C; Sotiriou, C; Cardoso, F; Loibl, S; Andre, F; Turner, N C.
Afiliação
  • Condorelli R; Department of Medical Oncolo, INSERM U981, Université Paris Sud, Gustave Roussy, Villejuif, France; Institute of Oncology and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
  • Mosele F; Department of Medical Oncolo, INSERM U981, Université Paris Sud, Gustave Roussy, Villejuif, France. Electronic address: Mariafernanda.MOSELE@gustaveroussy.fr.
  • Verret B; Department of Medical Oncolo, INSERM U981, Université Paris Sud, Gustave Roussy, Villejuif, France.
  • Bachelot T; Department of Medical Oncology, Cancer Research Center of Lyon Inserm, Lyon, France.
  • Bedard PL; Division of Medical Oncology & Hematolog, Department of Medicine, Princess Margaret Cancer Centre, Toronto, Canada.
  • Cortes J; Ramon y Cajal University Hospital, Madrid & Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Hyman DM; Memorial Sloan Kettering Cancer Center, New York.
  • Juric D; Massachusetts General Hospital (MGH), Boston.
  • Krop I; Dana-Farber Cancer Institute, Boston, USA.
  • Bieche I; Department of Genetics, Curie Institute, Paris, France.
  • Saura C; Department of Medical Oncolog, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Sotiriou C; J.C. Heuson Breast Cancer Translational Research Laborator, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium.
  • Cardoso F; Breast Uni, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
  • Loibl S; German Breast Group, Neu-Isenburg, Germany.
  • Andre F; Department of Medical Oncolo, INSERM U981, Université Paris Sud, Gustave Roussy, Villejuif, France.
  • Turner NC; Royal Marsden Hospital and Institute of Cancer Research, London, UK.
Ann Oncol ; 30(3): 365-373, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30715161
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Instabilidade Genômica / Terapia de Alvo Molecular Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Instabilidade Genômica / Terapia de Alvo Molecular Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article